Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,075 INR
Change Today 0.00 / 0.00%
Volume 0.0
CLPL On Other Exchanges
Symbol
Exchange
CLPL is not on other exchanges.
As of 7:05 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

caplin point laboratories (CLPL) Snapshot

Open
1,067
Previous Close
1,123
Day High
1,160
Day Low
1,066
52 Week High
04/9/15 - 1,364
52 Week Low
06/13/14 - 161.20
Market Cap
16.2B
Average Volume 10 Days
65.1K
EPS TTM
17.11
Shares Outstanding
15.1M
EX-Date
12/11/14
P/E TM
62.8x
Dividend
4.00
Dividend Yield
0.37%
Current Stock Chart for CAPLIN POINT LABORATORIES (CLPL)

Related News

No related news articles were found.

caplin point laboratories (CLPL) Related Businessweek News

No Related Businessweek News Found

caplin point laboratories (CLPL) Details

Caplin Point Laboratories Limited manufactures and sells pharmaceutical formulations in India and internationally. Its product portfolio includes analgesic and antipyretic, antacid, anthelmintic, anti-amoebic, anti-bacterials, antibiotic, anti-cold, antihistaminic, anti-diabetic, anti-hypertensive and anti-anginal, anti-malarial, and antirheumatic formulations. The company’s product line also comprises anti-spasmodic, anti-tubercular, anti-viral, bronchodilator, cortisone, cough syrup, diuretic, haematinic, oral rehydration salts, ointments and gels, urinary antibacterial, and vitamin supplements. In addition, it offers novel and special products, biotech and other lyophilized products, effervescent tablets, soft gel capsules, and medical and hospital consumables, as well as provides contract manufacturing services. Further, the company manufactures a range of creams and other external application products. Caplin Point Laboratories Limited was founded in 1990 and is based in Chennai, India.

Founded in 1990

caplin point laboratories (CLPL) Top Compensated Officers

Managing Director, Compliance Officer, Execut...
Total Annual Compensation: 588.4K
Chief Operating officer
Total Annual Compensation: 1.8M
Whole Time Director, Member of Audit Committe...
Total Annual Compensation: 633.4K
Compensation as of Fiscal Year 2014.

caplin point laboratories (CLPL) Key Developments

Caplin Point Laboratories Ltd Announces License and Distribution Agreement with Cycle Pharmaceuticals Limited

Caplin Point Laboratories Limited announced that a license and distribution agreement has been made and entered by and between Caplin Point Laboratories Limited, India and Cycle Pharmaceuticals Limited. Under this agreement, Caplin Point shall be responsible for developing and manufacturing identified liquid injectable products whereas Cycle Pharmaceuticals Limited shall be holding this ANDA and commercialize the same in USA. This is a product specific agreement for United States of America. Currently one product is featuring in the contract. Caplin Point has already received milestone payment for one product and the product development cum dossier preparation have just commenced.

Caplin Point Laboratories Limited and Fresenius Kabi USA, LLC Enter into License and Distribution Agreement

Caplin Point Laboratories Ltd. has announced that a license and distribution agreement has been made and entered by and between Caplin Point Laboratories Limited, India and Fresenius Kabi USA, LLC, a Delaware Limited Liability Company. Under this agreement, Caplin Point shall be responsible for developing and manufacturing identified parenteral products whereas Fresenius Kabi USA shall be holding these ANDAs and commercialize the same in USA. This is a product specific agreement for United States of America. Currently two products are featuring in the contract.

Caplin Point Laboratories Ltd Announces Resignation of Mohan Raj as Chief Financial Officer and Company Secretary

Caplin Point Laboratories Ltd has informed that Mr. S. Mohan Raj, Chief Financial Officer and Company Secretary of the Company, due to personal reasons has resigned and has been relieved from the services of the Company as at the close of February 13, 2015. The company is in the process of appointing a suitable person with the required qualification and experience. Meanwhile, the Board has requested the undersigned, Mr. M. Jayapal, Managing Director, to function as Compliance Officer of the Company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLPL:IN 1,074.80 INR 0.00

CLPL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLPL.
View Industry Companies
 

Industry Analysis

CLPL

Industry Average

Valuation CLPL Industry Range
Price/Earnings 51.2x
Price/Sales 7.9x
Price/Book 20.5x
Price/Cash Flow 42.6x
TEV/Sales 7.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAPLIN POINT LABORATORIES, please visit www.caplinpoint.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.